• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于审查临床试验方案的知识表示与工具支持。

Knowledge representation and tool support for critiquing clinical trial protocols.

作者信息

Rubin D L, Gennari J, Musen M A

机构信息

Center for Health Care Evaluation, VA Palo Alto Health Care System, Palo Alto, CA, USA.

出版信息

Proc AMIA Symp. 2000:724-8.

PMID:11079979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2243914/
Abstract

The increasing complexities of clinical trials have led to increasing costs for investigators and organizations that author and administer those trials. The process of authoring a clinical trial protocol, the document that specifies the details of the study, is usually a manual task, and thus authors may introduce subtle errors in medical and procedural content. We have created a protocol inspection and critiquing tool (PICASSO) that evaluates the procedural aspects of a clinical trial protocol. To implement this tool, we developed a knowledge base for clinical trials that contains knowledge of the medical domain (diseases, drugs, lab tests, etc.) and of specific requirements for clinical trial protocols (eligibility criteria, patient treatments, and monitoring activities). We also developed a set of constraints, expressed in a formal language, that describe appropriate practices for authoring clinical trials. If a clinical trial designed with PICASSO violates any of these constraints, PICASSO generates a message to the user and a list of inconsistencies for each violated constraint. To test our methodology, we encoded portions of a hypothetical protocol and implemented designs consistent and inconsistent with known clinical trial practice. Our hope is that this methodology will be useful for standardizing new protocols and improving their quality.

摘要

临床试验日益复杂,导致开展和管理这些试验的研究人员及机构成本不断增加。撰写临床试验方案(即规定研究细节的文件)的过程通常是一项手工任务,因此作者可能会在医学和程序内容中引入细微错误。我们创建了一个方案检查与评估工具(PICASSO),用于评估临床试验方案的程序方面。为实现此工具,我们开发了一个临床试验知识库,其中包含医学领域知识(疾病、药物、实验室检查等)以及临床试验方案的特定要求(入选标准、患者治疗和监测活动)。我们还开发了一组用形式语言表达的约束条件,用于描述撰写临床试验的适当做法。如果使用PICASSO设计的临床试验违反了任何这些约束条件,PICASSO会向用户生成一条消息,并列出每个违反约束条件的不一致之处。为测试我们的方法,我们对一个假设方案的部分内容进行了编码,并实施了与已知临床试验实践一致和不一致的设计。我们希望这种方法将有助于规范新方案并提高其质量。

相似文献

1
Knowledge representation and tool support for critiquing clinical trial protocols.用于审查临床试验方案的知识表示与工具支持。
Proc AMIA Symp. 2000:724-8.
2
Temporal knowledge representation for scheduling tasks in clinical trial protocols.用于临床试验方案中任务调度的时间知识表示。
Proc AMIA Symp. 2002:879-83.
3
TrialWiz: an ontology-driven tool for authoring clinical trial protocols.TrialWiz:一种用于编写临床试验方案的本体驱动工具。
AMIA Annu Symp Proc. 2008 Nov 6:1226.
4
Applying artificial intelligence to clinical guidelines: the GLARE approach.将人工智能应用于临床指南:GLARE方法。
Stud Health Technol Inform. 2008;139:273-82.
5
AIDS2: a decision-support tool for decreasing physicians' uncertainty regarding patient eligibility for HIV treatment protocols.艾滋病2:一种决策支持工具,用于减少医生在患者是否符合艾滋病毒治疗方案资格方面的不确定性。
Proc Annu Symp Comput Appl Med Care. 1993:429-33.
6
Cross-tool communication: from protocol authoring to eligibility determination.跨工具通信:从协议编写到资格判定。
Proc AMIA Symp. 2001:199-203.
7
Tool support for authoring eligibility criteria for cancer trials.支持编写癌症试验纳入标准的工具
Proc AMIA Symp. 1999:369-73.
8
Automated generation of patient-tailored electronic care pathways by translating computer-interpretable guidelines into hierarchical task networks.通过将计算机可解释的指南转换为分层任务网络,自动生成针对患者的定制化电子护理路径。
Artif Intell Med. 2013 Feb;57(2):91-109. doi: 10.1016/j.artmed.2012.08.008. Epub 2012 Nov 21.
9
Telematics for clinical guidelines: a conceptual modelling approach.
Stud Health Technol Inform. 1997;43 Pt A:314-8.
10
The role of protocols and professional judgement in emergency medical dispatching.预案及专业判断在紧急医疗调度中的作用
Eur J Emerg Med. 1995 Sep;2(3):136-48.

引用本文的文献

1
A knowledge base of clinical trial eligibility criteria.临床试验入选标准知识库。
J Biomed Inform. 2021 May;117:103771. doi: 10.1016/j.jbi.2021.103771. Epub 2021 Apr 1.
2
Leveraging Real-World Data for the Selection of Relevant Eligibility Criteria for the Implementation of Electronic Recruitment Support in Clinical Trials.利用真实世界数据为临床试验实施电子招募支持选择相关入选标准。
Appl Clin Inform. 2021 Jan;12(1):17-26. doi: 10.1055/s-0040-1721010. Epub 2021 Jan 13.
3
The representativeness of eligible patients in type 2 diabetes trials: a case study using GIST 2.0.2型糖尿病试验中符合条件患者的代表性:一项使用GIST 2.0的案例研究
J Am Med Inform Assoc. 2018 Mar 1;25(3):239-247. doi: 10.1093/jamia/ocx091.
4
GIST 2.0: A scalable multi-trait metric for quantifying population representativeness of individual clinical studies.GIST 2.0:一种用于量化个体临床研究人群代表性的可扩展多特征指标。
J Biomed Inform. 2016 Oct;63:325-336. doi: 10.1016/j.jbi.2016.09.003. Epub 2016 Sep 4.
5
Correlating eligibility criteria generalizability and adverse events using Big Data for patients and clinical trials.利用大数据关联患者和临床试验的资格标准普遍性及不良事件。
Ann N Y Acad Sci. 2017 Jan;1387(1):34-43. doi: 10.1111/nyas.13195. Epub 2016 Sep 6.
6
Optimizing Clinical Research Participant Selection with Informatics.利用信息学优化临床研究参与者的选择
Trends Pharmacol Sci. 2015 Nov;36(11):706-709. doi: 10.1016/j.tips.2015.08.007.
7
Biomedical informatics and outcomes research: enabling knowledge-driven health care.生物医学信息学与结果研究:推动知识驱动型医疗保健
Circulation. 2009 Dec 8;120(23):2393-9. doi: 10.1161/CIRCULATIONAHA.108.795526.

本文引用的文献

1
Role of clinical trials informatics in the NCI's cancer informatics infrastructure.临床试验信息学在国立癌症研究所癌症信息学基础设施中的作用。
Proc AMIA Symp. 1999:950-4.
2
Tool support for authoring eligibility criteria for cancer trials.支持编写癌症试验纳入标准的工具
Proc AMIA Symp. 1999:369-73.
3
Knowledge representation for computer-aided planning of controlled clinical trials: the PATriCIa project.用于对照临床试验计算机辅助规划的知识表示:PATriCIa项目
Methods Inf Med. 1997 Aug;36(3):172-8.
4
The separation of reviewing knowledge from medical knowledge.
Methods Inf Med. 1995 Mar;34(1-2):131-9.
5
A methodology for determining patients' eligibility for clinical trials.一种确定患者是否符合临床试验资格的方法。
Methods Inf Med. 1993 Aug;32(4):317-25.
6
Development of Design-a-Trial, a knowledge-based critiquing system for authors of clinical trial protocols.“设计试验”(Design-a-Trial)的开发,这是一种面向临床试验方案作者的基于知识的批判性分析系统。
Comput Methods Programs Biomed. 1994 Jun;43(3-4):283-91. doi: 10.1016/0169-2607(94)90081-7.
7
Knowledge engineering for a clinical trial advice system: uncovering errors in protocol specification.用于临床试验建议系统的知识工程:揭示方案规范中的错误
Bull Cancer. 1987;74(3):291-6.
8
Tracing expert thinking in clinical trial design.
Comput Biomed Res. 1989 Apr;22(2):190-208. doi: 10.1016/0010-4809(89)90025-6.
9
A model for critiquing based on automated medical records.
Comput Biomed Res. 1991 Aug;24(4):344-78. doi: 10.1016/0010-4809(91)90034-t.